Diabetes

  • A Stanford Medicine study found that metformin, a commonly prescribed diabetes drug associated with moderate weight loss, stimulates production of lac-phe, a molecule abundant after exercise.

  • New guidelines suggested for liver cancer

    A Stanford Medicine study identifies an easily measured biophysical property that can identify Type 2 diabetics at increased risk for liver cancer who don’t meet current screening guidelines.

  • AI helps manage Type 2 diabetes

    A new study led by Stanford Medicine indicates that an AI app can help Type 2 diabetic patients manage their blood glucose levels.

  • Screening for chronic kidney disease

    Many people don’t know they have chronic kidney disease until it progresses. A new study by Stanford Medicine researchers finds that screening would increase life expectancy in a cost-effective way.

  • Diabetes expert training program

    Stanford Medicine recently became the national center for a program to improve the diversity and increase the number of physician-scientists who are experts in Type 1 diabetes.

  • Mice with diabetes regain blood sugar control

    A technique developed at Stanford Medicine allows mice with diabetes to accept unmatched islet cells and durably restores blood sugar control without immunosuppression or graft-versus-host disease.

  • Blood sugar control helps teens’ brains

    Diabetes treatment technology improved teenagers’ blood sugar levels and benefited their brain structure and function, according to a study led by Stanford Medicine researchers.

  • Keto and Mediterranean good for diabetes

    In a trial of the two low-carb diets, both were similarly effective in controlling blood glucose. Keto’s more severe carb restrictions did not provide additional overall health benefits.

Related Websites